Skip to main content
Erschienen in: Diabetologia 3/2011

01.03.2011 | Short Communication

A novel surrogate index for hepatic insulin resistance

verfasst von: J. Vangipurapu, A. Stančáková, T. Kuulasmaa, J. Paananen, J. Kuusisto, E. Ferrannini, M. Laakso, the EGIR-RISC Study Group

Erschienen in: Diabetologia | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

In epidemiological and genetic studies surrogate indices are needed to investigate insulin resistance in different insulin-sensitive tissues. Our objective was to develop a surrogate index for hepatic insulin resistance.

Methods

A sample of 368 non-diabetic participants (age 43.0 ± 8.2 years, BMI 26.0 ± 4.0 kg/m2; mean ± SD) whose endogenous glucose production (EGP) was measured with [6-62H2]glucose in the fasting state and during the euglycaemic–hyperinsulinaemic clamp were included in the study. EGP multiplied by fasting plasma insulin (FPI) concentration was the reference measurement for liver insulin resistance (liver IR). Liver IR index was calculated with linear regression analysis including age, obesity indices, lipids, lipoproteins and several variables regulating glucose metabolism.

Results

The following variables were significantly associated with liver IR in multiple forward stepwise regression analysis: insulin AUC in an OGTT, fat mass, HDL-cholesterol and BMI. Liver IR index correlated significantly with EGP×FPI (r = 0.65, p < 0.001). In participants with abnormal glucose tolerance, the correlation of liver IR with EGP×FPI was slightly stronger (r = 0.69, p < 0.001) than in those with normal glucose tolerance (r = 0.62, p < 0.001).

Conclusions/interpretation

We generated a novel surrogate index for liver insulin resistance correlating strongly with EGP × FPI.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat DeFronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes. Diabetes 58:773–795CrossRefPubMed DeFronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes. Diabetes 58:773–795CrossRefPubMed
2.
Zurück zum Zitat DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395CrossRefPubMed DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395CrossRefPubMed
3.
Zurück zum Zitat Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203CrossRefPubMed Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203CrossRefPubMed
4.
Zurück zum Zitat Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA (1986) Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 77:1525–1532CrossRefPubMed Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA (1986) Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 77:1525–1532CrossRefPubMed
5.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
6.
Zurück zum Zitat Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diab Care 30:89–94CrossRef Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diab Care 30:89–94CrossRef
7.
Zurück zum Zitat Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (the European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (the European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed
8.
Zurück zum Zitat American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diab Care 29(Suppl 1):S43–S48 American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diab Care 29(Suppl 1):S43–S48
9.
Zurück zum Zitat Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA (2002) Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 283:E1135–E1143PubMed Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA (2002) Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 283:E1135–E1143PubMed
10.
Zurück zum Zitat Biddinger SB, Hernandez-Ono A, Rask-Madsen C et al (2008) Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7:125–134CrossRefPubMed Biddinger SB, Hernandez-Ono A, Rask-Madsen C et al (2008) Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7:125–134CrossRefPubMed
Metadaten
Titel
A novel surrogate index for hepatic insulin resistance
verfasst von
J. Vangipurapu
A. Stančáková
T. Kuulasmaa
J. Paananen
J. Kuusisto
E. Ferrannini
M. Laakso
the EGIR-RISC Study Group
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 3/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1966-7

Weitere Artikel der Ausgabe 3/2011

Diabetologia 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.